Anthem Blue Cross Blue Shield of Georgia prior authorization, page 68

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
Q4348Sentry sl matrix, per square centimeterStandard Local Prior Authorization Code List, Pg 152 Original policy
Q4349Mantle dl matrix, per square centimeterStandard Local Prior Authorization Code List, Pg 152 Original policy
Q4350Palisade dm matrix, per square centimeterStandard Local Prior Authorization Code List, Pg 152 Original policy
Q4351Enclose tl matrix, per square centimeterStandard Local Prior Authorization Code List, Pg 153 Original policy
Q4352Overlay sl matrix, per square centimeterStandard Local Prior Authorization Code List, Pg 153 Original policy
Q4353Xceed tl matrix, per square centimeterStandard Local Prior Authorization Code List, Pg 153 Original policy
Q4354Palingen dual-layer membrane and dual-layer palingen x-membrane, per square centimeter (add- on, list separately in addition to primary procedure)Standard Local Prior Authorization Code List, Pg 153 Original policy
Q4355Abiomend xplus membrane and abiomend xplus hydromembrane, per square centimeter (add-on, list separately in addition to primary procedure)Standard Local Prior Authorization Code List, Pg 153 Original policy
Q4356Abiomend membrane and abiomend hydromembrane, per square centimeter (add-on, list separately in addition to primary procedure)Standard Local Prior Authorization Code List, Pg 153 Original policy
Q4357Xwrap plus, per square centimeter (add-on, list separately in addition to primary procedure)Standard Local Prior Authorization Code List, Pg 153 Original policy
Q4358Xwrap dual, per square centimeter (add-on, list separately in addition to primary procedure)Standard Local Prior Authorization Code List, Pg 153 Original policy
Q4359Choriply, per square centimeter (add-on, list separately in addition to primary procedure)Standard Local Prior Authorization Code List, Pg 153 Original policy
Q4360Amchoplast fd, per square centimeter (add-on, list separately in addition to primary procedure)Standard Local Prior Authorization Code List, Pg 153 Original policy
Q4361Epixpress, per square centimeter (add-on, list separately in addition to primary procedure)Standard Local Prior Authorization Code List, Pg 153 Original policy
Q4362Cygnus disk, per square centimeter (add-on, list separately in addition to primary procedure)Standard Local Prior Authorization Code List, Pg 153 Original policy
Q4363Amnio burgeon membrane and hydromembrane, per square centimeter (add-on, list separately in addition to primary procedure)Standard Local Prior Authorization Code List, Pg 153 Original policy
Q4364Amnio burgeon xplus membrane and xplus hydromembrane, per square centimeter (add-on, list separately in addition to primary procedure)Standard Local Prior Authorization Code List, Pg 153 Original policy
Q4365Amnio burgeon dual-layer membrane, per square centimeter (add-on, list separately in addition to primary procedure)Standard Local Prior Authorization Code List, Pg 153 Original policy
Q4366Dual layer amnio burgeon x-membrane, per square centimeter (add-on, list separately in addition to primary procedure)Standard Local Prior Authorization Code List, Pg 153 Original policy
Q4367Amniocore sl, per square centimeter (add-on, list separately in addition to primary procedure)Standard Local Prior Authorization Code List, Pg 153 Original policy
Q5101Injection, filgrastim-sndz, biosimilar, (Zarxio), 1 mcgStandard Local Prior Authorization Code List, Pg 153 Original policy
Q5105Injection, epoetin alfa-epbx, biosimilar, (Retacrit) (for ESRD on dialysis), 100 unitsStandard Local Prior Authorization Code List, Pg 153 Original policy
Q5106Injection, epoetin alfa-epbx, biosimilar, (Retacrit) (for non-ESRD use), 1000 unitsStandard Local Prior Authorization Code List, Pg 153 Original policy
Q5107Injection, bevacizumab-awwb, biosimilar, (Mvasi), 10 mgStandard Local Prior Authorization Code List, Pg 153 Original policy
Q5108Injection, pegfilgrastim-jmdb (Fulphila), biosimilar, 0.5 mgStandard Local Prior Authorization Code List, Pg 153 Original policy
Q5110Injection, filgrastim-aafi, biosimilar, (Nivestym), 1 mcgStandard Local Prior Authorization Code List, Pg 153 Original policy
Q5111Injection, pegfilgrastim-cbqv, biosimilar, (Udenyca), 0.5 mgStandard Local Prior Authorization Code List, Pg 153 Original policy
Q5115Injection, rituximab-abbs, biosimilar, (Truxima), 10 mgStandard Local Prior Authorization Code List, Pg 153 Original policy
Q5118Injection, bevacizumab-bvcr, biosimilar, (Zirabev), 10 mgStandard Local Prior Authorization Code List, Pg 153 Original policy
Q5119Injection, rituximab-pvvr, biosimilar, (RUXIENCE), 10 mgStandard Local Prior Authorization Code List, Pg 153 Original policy
Q5120Injection, pegfilgrastim-bmez, biosimilar, (ZIEXTENZO), 0.5 mgStandard Local Prior Authorization Code List, Pg 153 Original policy
Q5122Injection, pegfilgrastim-apgf (Nyvepria), biosimilar, 0.5 mgStandard Local Prior Authorization Code List, Pg 153 Original policy
Q5125Injection, filgrastim-ayow, biosimilar, (Releuko), 1 mcgStandard Local Prior Authorization Code List, Pg 153 Original policy
Q5126Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mgStandard Local Prior Authorization Code List, Pg 153 Original policy
Q5127Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mgStandard Local Prior Authorization Code List, Pg 153 Original policy
Q5129Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mgStandard Local Prior Authorization Code List, Pg 153 Original policy
Q5130Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mgStandard Local Prior Authorization Code List, Pg 153 Original policy
Q5133Injection, tocilizumab-bavi (Tofidence), biosimilar, 1 mgStandard Local Prior Authorization Code List, Pg 153 Original policy
Q5135Injection, tocilizumab-aazg (Tyenne), biosimilar, 1 mgStandard Local Prior Authorization Code List, Pg 153 Original policy
Q5136Injection, denosumab-bbdz (Jubbonti/Wyost), biosimilar, 1 mgStandard Local Prior Authorization Code List, Pg 153 Original policy
Q5148Injection, filgrastim-txid (Nypozi), biosimilar, 1 mcgStandard Local Prior Authorization Code List, Pg 153 Original policy
Q5156Injection, tocilizumab-anoh (Avtozma), biosimilar, 1 mgStandard Local Prior Authorization Code List, Pg 153 Original policy
Q5157Injection, denosumab-bmwo (Stoboclo/Osenvelt), biosimilar, 1 mgStandard Local Prior Authorization Code List, Pg 154 Original policy
Q5158Injection, denosumab-bnht (Bomyntra/Conexxence), biosimilar, 1 mgStandard Local Prior Authorization Code List, Pg 154 Original policy
Q5159Injection, denosumab-dssb (Ospomyv/Xbryk), biosimilar, 1 mgStandard Local Prior Authorization Code List, Pg 154 Original policy
Q5166Injection, denosumab-desu (osvyrti/jubereq), biosimilar, 1 mgStandard Local Prior Authorization Code List, Pg 154 Original policy
Q5167Injection, denosumab-qbde (enoby/xtrenbo), biosimilar, 1 mgStandard Local Prior Authorization Code List, Pg 154 Original policy
Q5169Injection, pegfilgrastim-unne (armlupeg), biosimilar, 0.5 mgStandard Local Prior Authorization Code List, Pg 154 Original policy
Q5171Injection, denosumab-mobz (boncresa), biosimilar, 1 mgStandard Local Prior Authorization Code List, Pg 154 Original policy
S1091Stent, non-coronary, temporary, with delivery system (Propel)Standard Local Prior Authorization Code List, Pg 154 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.